Biogen has announced a definitive agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion, a move that would expand its presence in complement-mediated diseases, including ...

The next phase of weight management won’t be led by pharma, but by functional foods designed to work alongside GLP‑1 drugs, ...

A metabolic enzyme found in the support cells surrounding tumors may hold the key to predicting which cancer patients will ...

Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence ...

This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.

There’s a genuine medieval castle sitting on the Massachusetts coastline, and no, you haven’t accidentally stumbled into a fantasy novel. Hammond Castle in Gloucester is as real as your morning coffee ...